Sequel Pharmaceuticals (India) Private Limited
Produces pharmaceutical ingredients and bulk drugs for various clients.
2006 | Ambernath, Maharashtra (India) | Active
Sequel Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 5.80 Cr
- Company Age 18 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 Cr
- Satisfied Charges ₹ 36.09 Cr
- Revenue Growth %
- Profit Growth 93.21%
- Ebitda 93.28%
- Net Worth -0.02%
- Total Assets -0.30%
About Sequel Pharmaceuticals (India)
Sequel Pharmaceuticals (India) Private Limited (SPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 June 2006 and has a history of 18 years and eight months. Its registered office is in Ambernath, Maharashtra.
The Corporate was formerly known as Sequel Pharmachem Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.80 Cr.
The company currently has active open charges totaling ₹5.00 Cr. The company has closed loans amounting to ₹36.09 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nandadip Rasam and Ramchandra Parade serve as directors at the Company.
Company Details
- Location Ambernath, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239MH2006PTC162896
- Company No.
162896
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Sequel Pharmaceuticals (India) Private Limited
Explore comprehensive data for Sequel Pharmaceuticals (India) Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Sequel Pharmaceuticals (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandadip Rasam  | Director | 06-May-2023 | Current |
| Ramchandra Parade | Director | 18-Jun-2020 | Current |
Financial Performance of Sequel Pharmaceuticals (India).
Sequel Pharmaceuticals (India) Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 93.21% increase in profit. The company's net worth dipped by a decrease of 0.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sequel Pharmaceuticals (India)?
In 2018, Sequel Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹5.00 Cr
Satisfied Charges
₹36.09 Cr
Charges Breakdown by Lending Institutions
- Nkgsb Co-Op. Bank Ltd. : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Apr 2011 | Nkgsb Co-Op. Bank Ltd. | ₹5.00 Cr | Open |
| 22 Dec 2007 | Corporation Bank | ₹29.31 Cr | Satisfied |
| 10 Aug 2007 | Janakalyan Sahakari Bank Ltd. | ₹4.18 Cr | Satisfied |
| 12 Apr 2007 | Janakalyan Sahakari Bank Ltd. | ₹1.00 Cr | Satisfied |
| 12 Apr 2007 | Janakalyan Sahakari Bank Limited | ₹1.60 Cr | Satisfied |
How Many Employees Work at Sequel Pharmaceuticals (India)?
Unlock and access historical data on people associated with Sequel Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sequel Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sequel Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Sequel Pharmaceuticals (India)
Recent activity within the organization
- Annual General Meeting
Sequel Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Sequel Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Nandadip Sakharam Rasam was appointed as a Director was appointed as a Director on 06 May 2023 & has been associated with this company since 1 year 10 months .
- Director Appointment
Ramchandra Haridas Parade was appointed as a Director was appointed as a Director on 18 Jun 2020 & has been associated with this company since 4 years 9 months .
- Charges
A charge registered on 10 Aug 2007 via Charge ID 10063597 with Janakalyan Sahakari Bank Ltd. was fully satisfied on 07 Jun 2017.
- Charges
A charge registered on 12 Apr 2007 via Charge ID 10096643 with Janakalyan Sahakari Bank Limited was fully satisfied on 07 Jun 2017.
Frequently asked questions
What is the Incorporation or founding date of Sequel Pharmaceuticals (India) Private Limited?
Sequel Pharmaceuticals (India) Private Limited was incorporated on 28 Jun 2006.
What is authorized share capital and paid-up capital of Sequel Pharmaceuticals (India) Private Limited?
The authorized share capital of Sequel Pharmaceuticals (India) Private Limited is ₹ 6.00 Cr and paid-up capital is ₹ 5.80 Cr.
Who are the current board members & directors of Sequel Pharmaceuticals (India) Private Limited?
Currently 2 directors are associated with Sequel Pharmaceuticals (India) Private Limited.
- Nandadip Sakharam Rasam
- Ramchandra Haridas Parade
What is the registered address of Sequel Pharmaceuticals (India) Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Sequel Pharmaceuticals (India) Private Limited is N-46 Midc Anand Nagar, India, Ambernath, Maharashtra, 421504.
What is the corporate identification number (CIN) and company number of Sequel Pharmaceuticals (India) Private Limited?
The corporate identification number (CIN) of Sequel Pharmaceuticals (India) Private Limited is U24239MH2006PTC162896 and the company number is 162896 as per Ministry of Corporate Affairs (MCA).
What change has been observed in the net worth of Sequel Pharmaceuticals (India) Private Limited, and by what percentage?
The financial reports for the fiscal year 2020 indicates that The net worth of Sequel Pharmaceuticals (India) Private Limited has experienced an downturn of -0.02%.
What are the total open charges for Sequel Pharmaceuticals (India) Private Limited?
As per the financial statements for fiscal Year 2020, The total open charges for Sequel Pharmaceuticals (India) Private Limited amount to ₹ 5.00 Cr.
When was the last Balance Sheet of Sequel Pharmaceuticals (India) Private Limited filed with the ROC?
The most recent Balance Sheet for Sequel Pharmaceuticals (India) Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
MK
Mohan KadamDirectorSJ
Santosh JoshiDirectorSS
Satish SawantDirectorVJ
Varsha JoshiDirectorSS
Supriya SawantDirectorSM
Saili MoreDirector